| 000 | 01906 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517132410.0 | ||
| 264 | 0 | _c20180220 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.14321 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPetrachi, Tiziana | |
| 245 | 0 | 0 |
_aTherapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma. _h[electronic resource] |
| 260 |
_bOncotarget _cJan 2017 |
||
| 300 |
_a6914-6928 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAldehyde Dehydrogenase _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aMetformin _xpharmacology |
| 650 | 0 | 4 |
_aMicrophthalmia-Associated Transcription Factor _xgenetics |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xdrug effects |
| 650 | 0 | 4 |
_aPhenformin _xpharmacology |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSpheroids, Cellular |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aRomagnani, Alessandra | |
| 700 | 1 | _aAlbini, Adriana | |
| 700 | 1 | _aLongo, Caterina | |
| 700 | 1 | _aArgenziano, Giuseppe | |
| 700 | 1 | _aGrisendi, Giulia | |
| 700 | 1 | _aDominici, Massimo | |
| 700 | 1 | _aCiarrocchi, Alessia | |
| 700 | 1 | _aDallaglio, Katiuscia | |
| 773 | 0 |
_tOncotarget _gvol. 8 _gno. 4 _gp. 6914-6928 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.14321 _zAvailable from publisher's website |
| 999 |
_c26742674 _d26742674 |
||